Chromosomal Aberrations Detected by Chromogenic In Situ Hybridization in Abdominal Wall Endometriosis After Cesarean SectionJEONG, Kyungah; LEE, Sangho; KIM, Insun et al.International journal of gynecological pathology. 2012, Vol 31, Num 4, pp 328-334, issn 0277-1691, 7 p.Article

Evaluation of Dual Immunohistochemistry and Chromogenic In Situ Hybridization for HER2 on a Single SectionREISENBICHLER, Emily S; HORTON, Debra; RASCO, Marva et al.American journal of clinical pathology. 2012, Vol 137, Num 1, pp 102-110, issn 0002-9173, 9 p.Article

Chromogenic and fluorescent in situ hybridization in breast cancer : In situ techniquesLAMBROS, Maryou B. K; NATRAJAN, Rachael; REIS-FILHO, Jorge S et al.Human pathology. 2007, Vol 38, Num 8, pp 1105-1122, issn 0046-8177, 18 p.Article

EGFR amplification and lack of activating mutations in metaplastic breast carcinomasREIS-FILHO, J. S; PINHEIRO, C; REIS, R. M et al.Journal of pathology. 2006, Vol 209, Num 4, pp 445-453, issn 0022-3417, 9 p.Article

Visualization of FISH Probes by Dual-Color Chromogenic In Situ HybridizationHOFF, Kirsten; JØRGENSEN, Jan T; MÜLLER, Sven et al.American journal of clinical pathology. 2010, Vol 133, Num 2, pp 205-211, issn 0002-9173, 7 p.Article

Pleomorphic lobular carcinoma of the breast : role of comprehensive molecular pathology in characterization of an entityREIS-FILHO, Jorge S; SIMPSON, Pete T; PALACIOS, Jose et al.Journal of pathology. 2005, Vol 207, Num 1, pp 1-13, issn 0022-3417, 13 p.Article

Aurora-A gene is frequently amplified in basal-like breast cancerSTAFF, Synnöve; ISOLA, Jorma; JUMPPANEN, Mervi et al.Oncology reports. 2010, Vol 23, Num 2, pp 307-312, issn 1021-335X, 6 p.Article

Fetal macrophages are not present in the myometrium of women with labor at termCHONG JAI KIM; KIM, Jung-Sun; YEON MEE KIM et al.American journal of obstetrics and gynecology. 2006, Vol 195, Num 3, pp 829-833, issn 0002-9378, 5 p.Conference Paper

Correlation of MYCN amplification with MCM7 protein expression in neuroblastomas: A chromogenic in situ hybridization study in paraffin sectionsTSAI, Hsien-Yu; HSI, Bae-Li; HUNG, Iou-Jih et al.Human pathology. 2004, Vol 35, Num 11, pp 1397-1403, issn 0046-8177, 7 p.Article

Dual-colour chromogenic in-situ hybridization is a potential alternative to fluorescence in-situ hybridization in HER2 testingHWANG, Cheng-Cheng; PINTYE, Mariann; CHANG, Liang-Che et al.Histopathology. 2011, Vol 59, Num 5, pp 984-992, issn 0309-0167, 9 p.Article

Detection of SYT and EWS Gene Rearrangements by Dual-Color Break-Apart CISH in Liquid-Based Cytology Samples of Synovial Sarcoma and Ewing Sarcoma/ Primitive Neuroectodermal TumorKUMAGAI, Arisa; MOTOI, Toru; TSUJI, Kaori et al.American journal of clinical pathology. 2010, Vol 134, Num 2, pp 323-331, issn 0002-9173, 9 p.Article

Mixed micropapillary―ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct componentsMARCHIO, Caterina; IRAVANI, Marjan; SCHMITT, Fernando C et al.Journal of pathology (Print). 2009, Vol 218, Num 3, pp 301-315, issn 0022-3417, 15 p.Article

Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: Does it measure up to fluorescence in situ hybridization?BHARGAVA, Rohit; LAL, Priti; BEIYUN CHEN et al.American journal of clinical pathology. 2005, Vol 123, Num 2, pp 237-243, issn 0002-9173, 7 p.Article

Her-2/neu and topoisomerase IIα gene amplification and protein expression in invasive breast carcinomas : Chromogenic in situ hybridization and immunohistochemical analysesBHARGAVA, Rohit; LAL, Priti; BEIYUN CHEN et al.American journal of clinical pathology. 2005, Vol 123, Num 6, pp 889-895, issn 0002-9173, 7 p.Article

Chromogenic In Situ Hybridization Is a Reliable Method for Detecting HER2 Gene Status in Breast Cancer : A Multicenter Study Using Conventional Scoring Criteria and the New ASCO/CAP RecommendationsYUN GONG; SWEET, William; DUH, Yi-Jing et al.American journal of clinical pathology. 2009, Vol 131, Num 4, pp 490-497, issn 0002-9173, 8 p.Article

Evaluation of HER2 gene status in breast cancer by chromogenic in situ hybridization : Comparison with immunohistochemistryKOUNELIS, Sophia; KAPRANOS, Nikiforos; MALAMOS, Nikolaos et al.Anticancer research. 2005, Vol 25, Num 2A, pp 939-946, issn 0250-7005, 8 p.Article

Gene amplification and protein overexpression of HER-2/neu in human extrahepatic cholangiocarcinoma as detected by chromogenic in situ hybridization and immunohistochemistry : its prognostic implication in node-positive patientsKIM, H. J; YOO, T. W; SOHN, J. H et al.Annals of oncology. 2007, Vol 18, Num 5, pp 892-897, issn 0923-7534, 6 p.Article

Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breastMARCHIO, C; IRAVANI, M; SCHMITT, F. C et al.Journal of pathology. 2008, Vol 215, Num 4, pp 398-410, issn 0022-3417, 13 p.Article

Recherche de l'amplification du gène HER2 : la CISH est-elle une alternative à la technique FISH ? = HER2 gene amplification assay: is CISH an alternative to FISH?DENOUX, Yves; ARNOULD, Laurent; FICHE, Maryse et al.Annales de pathologie (Paris). 2003, Vol 23, Num 6, pp 617-622, issn 0242-6498, 6 p.Article

Immunoglobulin Heavy-Chain Fluorescence In Situ Hybridization-Chromogenic In Situ Hybridization DNA Probe Split Signal in the Clonality Assessment of Lymphoproliferative Processes on Cytological SamplesZEPPA, Pio; SOSA FERNANDEZ, Laura Virginia; COZZOLINO, Immacolata et al.Cancer cytopathology. 2012, Vol 120, Num 6, pp 390-400, issn 1934-662X, 11 p.Article

Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcomaTHOMAS, Dafydd G; GIORDANO, Thomas J; SANDERS, Donita et al.Cancer. 2005, Vol 103, Num 4, pp 830-838, issn 0008-543X, 9 p.Article

Chromogenic In Situ Hybridization: A Multicenter Study Comparing Silver In Situ Hybridization With FISHBARTLETT, J. M. S; CAMPBELL, Fiona M; MORGAN, John M et al.American journal of clinical pathology. 2009, Vol 132, Num 4, pp 514-520, issn 0002-9173, 7 p.Article

Emerging Technologies for Assessing HER2 AmplificationPENAULT-LLORCA, Fridirique; BILOUS, Michael; DOWSETT, Mitch et al.American journal of clinical pathology. 2009, Vol 132, Num 4, pp 539-548, issn 0002-9173, 10 p.Article

Predictive markers in breast cancer : the presentPAYNE, S. J. L; BOWEN, R. L; JONES, J. L et al.Histopathology. 2008, Vol 52, Num 1, pp 82-90, issn 0309-0167, 9 p.Article

Erlotinib Treatment in Patients with Advanced Lung Adenocarcinoma with CISH-positive and CISH-negative EGFR Gene AlterationsHOU, Ming-Mo; HUANG, Shiu-Feng; HSIEH, Jia-Juan et al.Anticancer research. 2012, Vol 32, Num 3, pp 1107-1112, issn 0250-7005, 6 p.Article